Citigroup »

Seres Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $333k 238k 1.40
2023-09-30 $1.5M 734k 2.00
2023-03-31 $2.6M 451k 5.67
2022-12-31 $1.6M 282k 5.60
2022-09-30 $1.2M 191k 6.42
2021-12-31 $2.2M 267k 8.33
2021-03-31 $4.1M 201k 20.59
2020-12-31 $398k 16k 24.50
2020-09-30 $287k 10k 28.33
2020-06-30 $247k 52k 4.75
2020-03-31 $56k 16k 3.54
2019-12-31 $47k 14k 3.42
2019-09-30 $23k 4.7k 4.87
2019-06-30 $25k 8.0k 3.12
2019-03-31 $49k 7.1k 6.81
2018-12-31 $27k 5.7k 4.72
2018-09-30 $43k 5.7k 7.49
2018-06-30 $9.0k 1.0k 9.00
2018-03-31 $8.0k 1.1k 7.24
2017-12-31 $12k 1.2k 10.21
2017-09-30 $16k 1.1k 13.70
2017-06-30 $17k 1.2k 13.70
2017-03-31 $11k 1.0k 10.92
2016-12-31 $75k 7.6k 9.86
2016-09-30 $162k 13k 12.31
2016-06-30 $233k 8.0k 28.99
2015-12-31 $281k 8.0k 35.08
2015-09-30 $0 3.7k 0.00